ArticleThe Journal of clinical investigation2022

Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer.

Shigeki Nanjo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.